UK markets open in 45 minutes

RepliCel Life Sciences Inc. (RP.V)

TSXV - TSXV Real-time price. Currency in CAD
Add to watchlist
0.05500.0000 (0.00%)
At close: 03:56PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
353.735
353.735
353.735
353.735
Operating expenses
Research development
609.757
623.964
1,149
819.403
Selling general and administrative
1,211
1,125
1,506
884.704
Total operating expenses
1,818
1,746
2,652
1,682
Operating income or loss
-1,464
-1,393
-2,298
-1,328
Interest expense
1.803
6.701
5.528
0
Total other income/expenses net
1,396
656.123
-1,769
-252.376
Income before tax
-69.289
-743.228
-4,073
-1,580
Income from continuing operations
-69.287
-743.228
-4,073
-1,580
Net income
-69.287
-743.228
-4,073
-1,580
Net income available to common shareholders
-69.287
-743.228
-4,073
-1,580
Basic EPS
-0.02
-0.02
-0.13
-0.06
Diluted EPS
-0.02
-0.02
-0.13
-0.06
Basic average shares
46,234
37,768
32,487
26,961
Diluted average shares
46,234
37,768
32,487
26,961